Drug Research

The creation of a tool that can enable organic chemical processes that were not possible before has given the pharmaceutical business new ways to make effective drugs more quickly. In the past, most drugs were put together using alkyl building...

Quick delivery of toxicological materials According to Alejandro Fernandez Martell and James Berrie from Lonza, a bottleneck has developed in the supply of toxicological data to support INDs for novel therapies and, therefore, delivery of FIH studies, as a result...

ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, and Sitero LLC, a next-generation clinical trial solutions provider, today announced an expansion of their strategic partnership. This collaboration integrates Sitero's unified eClinical technology platform...

The radiopharmaceutical industry is growing very quickly. In the past few years, there have been more mergers and acquisitions (M&A) and partnerships. Investors can find good business chances by learning more about this field. Recent mergers, purchases, and joint deals...

The FDA has granted breakthrough status to an antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion agreement last year. The pharma firm said that GSK5764227 (GSK'227, formerly known as HS-20093) has been granted the...

Bayer and NextRNA Therapeutics, a biotechnology company, announced that they would be working together to create a new type of small molecule cancer drug. The two companies agreed to a deal that could be worth over $500 million. The two...

The capacity of a cell line to create a biologic that is both safe and stable in large numbers may be considerably improved by the use of a variety of procedures by those who develop pharmaceuticals. On the other...